3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate has been researched along with Cardiovascular Stroke in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kelley, M; Li, L; Vessey, DA | 1 |
1 other study(ies) available for 3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate and Cardiovascular Stroke
| Article | Year |
|---|---|
P2X7 receptor agonists pre- and postcondition the heart against ischemia-reperfusion injury by opening pannexin-1/P2X₇ channels.
Topics: Adenosine Triphosphate; Analysis of Variance; Animals; Cardiotonic Agents; Connexins; Disease Models, Animal; Drug Administration Schedule; Lysophospholipids; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Nerve Tissue Proteins; Perfusion; Purinergic P2X Receptor Agonists; Purinergic P2X Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Lysosphingolipid; Receptors, Purinergic P2X7; Sphingosine; Time Factors; Ventricular Function, Left; Ventricular Pressure | 2011 |